Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anlotinib, Vincristine and Irinotecan (AVI) for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial
Oncologist 2021 Feb 20;[EPub Ahead of Print], J Xu, L Xie, X Sun, K Liu, X Tang, T Yan, R Yang, W Guo, J GuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.